Relapsed or refractory Hodgkin lymphoma - pembrolizumab initial PBS authority application form (PB232)

This information was printed Monday 27 May 2019 from https://www.humanservices.gov.au/organisations/health-professionals/forms/pb232 It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.humanservices.gov.au/individuals/site-notices when using this material.

Page last updated: 10 April 2019